Patients Make New Medicines Possible

Pieris Pharmaceuticals is currently enrolling patients in respiratory and immuno-oncology clinical trials. New treatments are made possible by volunteers who participate in clinical trials and we highly encourage and welcome your participation.

Respiratory Trials

A Phase 2 Dose-escalating Trial of PRS-060 for Asthma

Our Phase 2 study is designed to investigate the safety, tolerability, pharmacokinetics, and efficacy of multiple doses of PRS-060, a promising drug candidate being developed to treat asthma. PRS-060 will be administered by oral inhalation to subjects with moderate asthma.

About PRS-060 Dose-escalating Clinical Trial

Immuno-Oncology Trials

A Phase 1 Study of Cinrebafusp Alfa to Treat HER2-Positive Cancers

Our phase 1 study is evaluating cinrebafusp alfa in patients with HER2-expressing tumors.